ISSN: 0889-8588
Journal Home
Journal Guideline
Hematology/Oncology Clinics of North America Q2 Unclaimed
Hematology/Oncology Clinics of North America is a journal indexed in SJR in Hematology and Oncology with an H index of 95. It has an SJR impact factor of 0,705 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,705.
Hematology/Oncology Clinics of North America focuses its scope in these topics and keywords: treatment, approach, surgery, human, blood, tool, ultimate, emission, oncology, structure, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -


- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,705
SJR Impact factor95
H Index93
Total Docs (Last Year)275
Total Docs (3 years)5592
Total Refs553
Total Cites (3 years)238
Citable Docs (3 years)2.29
Cites/Doc (2 years)60.13
Ref/DocOther journals with similar parameters
Cytokine: X Q2
Cytokine Q2
Hematological Oncology Q2
Platelets Q2
Stem Cells and Development Q2
Compare this journals
Aims and Scope
Best articles by citations
IMMUNOREGULATORY MECHANISMS IN MULTIPLE MYELOMA
View moreHIV-ASSOCIATED HODGKIN'S DISEASE
View moreCLINICAL ASPECTS OF APLASTIC ANEMIA
View moreENDOCRINOPATHY AND ECTOPIC HORMONES IN MALIGNANCY
View morePALLIATIVE MEDICINE AND THE MEDICAL ONCOLOGIST
View moreTHERAPY-RELATED MYELOID LEUKEMIA
View moreHEMOLYTIC DISORDERS ASSOCIATED WITH CANCER
View moreCLINICAL COURSE AND THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA AND CHEMOTHERAPY
View moreTreatment of Therapy-Related Acute Myelogenous Leukemia and Myelodysplastic Syndromes
View morePathology of Epithelial Tumors
View moreAUTOLOGOUS TRANSPLANTATION FOR THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA
View moreMONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AND SOLITARY PLASMACYTOMA
View moreINNOVATIVE THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA
View moreEarly Diagnosis and Screening
View moreETIOLOGY AND PATHOGENESIS OF AIDS-RELATED NON-HODGKIN'S LYMPHOMA
View moreCAN SCREENING FOR EARLY-STAGE PROSTATE CANCER BE RATIONALIZED?
View morePULMONARY COMPLICATIONS
View moreINTRAEMBRYONIC HEMATOPOIETIC STEM CELLS
View moreBIOLOGY AND MANAGEMENT OF AIDS-ASSOCIATED PRIMARY CNS LYMPHOMAS
View moreBIOLOGY AND THERAPY OF IMMUNOGLOBULIN DEPOSITION DISEASES
View moreTARGETED THERAPY FOR LYMPHOMA WITH PEPTIDES
View moreMALIGNANT HISTIOCYTIC DISORDERS IN CHILDREN
View moreMALIGNANT HISTIOCYTOSIS
View morePROGNOSTIC MARKERS IN RESECTABLE NON-SMALL CELL LUNG CANCER
View more
Comments